Hypoxia-inducible factor augments experimental colitis through an MIF-dependent inflammatory signaling cascade. Shah YM, Ito S, Morimura K, Chen C, Yim SH, Haase VH, Gonzalez FJ (2008) Gastroenterology 134: 2036-48, 2048.e1-3 Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor. Rankin EB, Tomaszewski JE, Haase VH (2006) Cancer Res 66: 2576-83 The role of VHL in clear-cell renal cell carcinoma and its relation to targeted therapy. Clark PE (2009) Kidney Int 76: 939-45 Hypoxia-inducible factor-1 inhibition in combination with temozolomide treatment exhibits robust antitumor efficacy in vivo. Li L, Lin X, Shoemaker AR, Albert DH, Fesik SW, Shen Y (2006) Clin Cancer Res 12: 4747-54 Knockdown of aberrantly upregulated aryl hydrocarbon receptor reduces tumor growth and metastasis of MDA-MB-231 human breast cancer cell line. Goode GD, Ballard BR, Manning HC, Freeman ML, Kang Y, Eltom SE (2013) Int J Cancer 133: 2769-80 Inactivation of the arylhydrocarbon receptor nuclear translocator (Arnt) suppresses von Hippel-Lindau disease-associated vascular tumors in mice. Rankin EB, Higgins DF, Walisser JA, Johnson RS, Bradfield CA, Haase VH (2005) Mol Cell Biol 25: 3163-72 ARNT as a Novel Antifibrotic Target in CKD. Haase VH (2019) Am J Kidney Dis 73: 281-284 Overexpression of Cu/Zn-superoxide dismutase and/or catalase accelerates benzo(a)pyrene detoxification by upregulation of the aryl hydrocarbon receptor in mouse endothelial cells. Wang Z, Yang H, Ramesh A, Roberts LJ, Zhou L, Lin X, Zhao Y, Guo Z (2009) Free Radic Biol Med 47: 1221-9 Inhibition of liver methionine adenosyltransferase gene expression by 3-methylcolanthrene: protective effect of S-adenosylmethionine. Carretero MV, Latasa MU, Garcia-Trevijano ER, Corrales FJ, Wagner C, Mato JM, Avila MA (2001) Biochem Pharmacol 61: 1119-28 Meat intake, heterocyclic amine exposure, and metabolizing enzyme polymorphisms in relation to colorectal polyp risk. Shin A, Shrubsole MJ, Rice JM, Cai Q, Doll MA, Long J, Smalley WE, Shyr Y, Sinha R, Ness RM, Hein DW, Zheng W (2008) Cancer Epidemiol Biomarkers Prev 17: 320-9 Aryl hydrocarbon receptor activation and cytochrome P450 1A induction by the mitogen-activated protein kinase inhibitor U0126 in hepatocytes. Andrieux L, Langouët S, Fautrel A, Ezan F, Krauser JA, Savouret JF, Guengerich FP, Baffet G, Guillouzo A (2004) Mol Pharmacol 65: 934-43 D-amino acid oxidase generates agonists of the aryl hydrocarbon receptor from D-tryptophan. Nguyen LP, Hsu EL, Chowdhury G, Dostalek M, Guengerich FP, Bradfield CA (2009) Chem Res Toxicol 22: 1897-904 Structural identification of Diindole agonists of the aryl hydrocarbon receptor derived from degradation of indole-3-pyruvic acid. Chowdhury G, Dostalek M, Hsu EL, Nguyen LP, Stec DF, Bradfield CA, Guengerich FP (2009) Chem Res Toxicol 22: 1905-12 Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk. Long JR, Egan KM, Dunning L, Shu XO, Cai Q, Cai H, Dai Q, Holtzman J, Gao YT, Zheng W (2006) Pharmacogenet Genomics 16: 237-43 Genetic polymorphisms in estrogen-metabolizing genes and breast cancer survival. Long JR, Cai Q, Shu XO, Cai H, Gao YT, Zheng W (2007) Pharmacogenet Genomics 17: 331-8 Regulation of the activity and expression of aryl hydrocarbon receptor by ethanol in mouse hepatic stellate cells. Zhang HF, Lin XH, Yang H, Zhou LC, Guo YL, Barnett JV, Guo ZM (2012) Alcohol Clin Exp Res 36: 1873-81 Inhibition of miR-29 has a significant lipid-lowering benefit through suppression of lipogenic programs in liver. Kurtz CL, Fannin EE, Toth CL, Pearson DS, Vickers KC, Sethupathy P (2015) Sci Rep 5: 12911
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.